Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation (By similarity). Additionally we are shipping MELK Kits (24) and MELK Proteins (10) and many more products for this protein.
Showing 10 out of 142 products:
Human Monoclonal MELK Primary Antibody for ICC, FACS - ABIN969538
Nakano, Joshi, Visnyei, Hu, Watanabe, Lam, Wexler, Saigusa, Nakamura, Laks, Mischel, Viapiano, Kornblum: Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway. in Neuro-oncology 2011
Show all 2 Pubmed References
Human Polyclonal MELK Primary Antibody for ELISA, WB - ABIN263108
Nagase, Seki, Ishikawa, Tanaka, Nomura: Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1. in DNA research : an international journal for rapid publication of reports on genes and genomes 1996
Human Polyclonal MELK Primary Antibody for - ABIN2017585
Hu, Ru, Xiao, Chaturbedi, Hoa, Tian, Zhang, Ke, Yan, Nelson, Li, Gramer, Yu, Siegel, Zhang, Jia, Jadus, Limoli, Linskey, Xing, Zhou: Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneity. in PLoS ONE 2013
Human Polyclonal MELK Primary Antibody for WB - ABIN2475560
Niesler, Myburgh, Moore: The changing AMPK expression profile in differentiating mouse skeletal muscle myoblast cells helps confer increasing resistance to apoptosis. in Experimental physiology 2007
Show all 2 Pubmed References
MELK is a host factor required for optimal uncoating of the HIV-1 core to promote viral cDNA synthesis.
Here, the authors report that mutagenizing MELK with CRISPR/Cas9 has no effect on the fitness of basal breast cancer cell lines or cell lines from six other cancer types. Cells that harbor null mutations in MELK exhibit wild-type doubling times, cytokinesis, and anchorage-independent growth.
MELK-inhibitor has a role in triple-negative breast cancer cells demonstrating context-dependent response with p53 (show TP53 Antibodies) as a key determinant
MELK is an oncogenic kinase involved in the pathogenesis and recurrence of hepatocellular carcinoma.
Inhibition or depletion of MELK reduced cell proliferation and anchorage-dependent and -independent growth in various ovarian cancer cell lines through a G2/M cell cycle arrest, eventually resulting in apoptosis.
Report IL11RA (show IL11RA Antibodies) and MELK amplification in gastric cancer cell lines and primary gastric adenocarcinomas.
MELK expression in hepatocellular carcinoma is extremely intense compared to its expression reported in other types of cancer and could be a promising effective tumor marker of HCC (show FAM126A Antibodies).
targeting MELK by the inhibition of both its catalytic activity and its protein stability might sensitize tumours to DNA-damaging agents or radiation therapy by lowering the DNA-damage threshold
Together, these data indicate that MELK is a normally non-essential kinase, but is critical for basal-like breast cancer.
EZH2 (show EZH2 Antibodies) protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1 (show FOXM1 Antibodies)-dependent manner
MELK promotes cell migration and invasion via the FAK (show PTK2 Antibodies)/Paxillin (show PXN Antibodies) pathway, and plays an important role in the occurrence and development of gastric cancer.
Phosphorylation of the activation loop of MPK38 induces its movement resulting in kinase activation.
These results indicate that Trx (show TXN Antibodies) functions as a physiological inhibitor of MPK38, which plays an important role in inducing ASK1 (show MAP3K5 Antibodies)-, TGF-beta (show TGFB1 Antibodies), and p53 (show TP53 Antibodies)-mediated activity
an important role for MPK38-mediated phosphorylation of PDK1 (show PDPK1 Antibodies) in the negative regulation of PDK1 (show PDPK1 Antibodies) activity.
MPK38 may act as a novel regulator for promoting p53 (show TP53 Antibodies) activity through direct phosphorylation of p53 (show TP53 Antibodies) at Ser (show SIGLEC1 Antibodies)(15).
Upregulation of maternal embryonic leucine zipper kinase is associated with mammary tumor.
MELK is necessary for proliferation of embryonic and postnatal MNP and suggest that it regulates the transition from GFAP (show GFAP Antibodies)-expressing progenitors to rapid amplifying progenitors in the postnatal brain.
The characterization of two novel E2F (show E2F1 Antibodies) target genes, chromosome condensation-related SMC-associated protein 1 (Cnap1 (show NCAPD2 Antibodies)) and maternal embryonic leucine zipper kinase (Melk) is reported.
MPK38 physically interacts with ASK1 (show MAP3K5 Antibodies) in vivo and acts as a positive upstream regulator of ASK1 (show MAP3K5 Antibodies)
Melk-like gene may play a role in primitive hematopoiesis by affecting the expression of genes critical for hematopoiesis.
Overexpression of xMELK leads to failure of cytokinesis and impairs accumulation RhoA- a pivotal regulator of cytokinesis.
These results demonstrate the presence of a mitochondrial targeting signal at the N-terminus of the MC domain of MELK. This mitochondrial targeting signal was also functional in human HeLa cells.[MELK]
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation (By similarity). Also plays a role in primitive hematopoiesis, possibly by affecting the expression of genes critical for hematopoiesis.
maternal embryonic leucine zipper kinase
, maternal embryonic leucine zipper kinase-like
, pEg3 kinase
, protein kinase Eg3
, protein kinase PK38
, tyrosine-protein kinase MELK
, Protein kinase Eg3